Panagora Asset Management Inc Amgen Inc Transaction History

Panagora Asset Management Inc

$19.7 Billion
Q2 2024

A detailed history of Panagora Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 212,440 shares of AMGN stock, worth $67.1 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

212,440

Previous 7,860 2602.8%

Holding current value

$67.1 Million

Previous $2.23 Million 2871.17%

% of portfolio

0.34%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $53.8 Million - $65.3 Million	204,580 Added 2602.8%	212,440 $66.4 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $313,233 - $378,112	-1,165 Reduced 12.91%	7,860 $2.23 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $229,874 - $259,325	-899 Reduced 9.06%	9,025 $2.6 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $642,393 - $797,549	2,938 Added 42.06%	9,924 $2.67 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $101,349 - $119,844	473 Added 7.26%	6,986 $1.55 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $697,465 - $850,092	-3,089 Reduced 32.17%	6,513 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.22 Million - $1.55 Million	-5,315 Reduced 35.63%	9,602 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $72,500 - $81,767	323 Added 2.21%	14,917 $3.36 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $563,624 - $627,215	-2,443 Reduced 14.34%	14,594 $3.55 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $1.95 Million - $2.16 Million	8,914 Added 109.74%	17,037 $4.12 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $488,250 - $558,758	-2,455 Reduced 23.21%	8,123 $1.83 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $19,528 - $22,880	-92 Reduced 0.86%	10,578 $2.25 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $58.7 Million - $65.1 Million	-251,220 Reduced 95.93%	10,670 $2.6 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $26.3 Million - $30.7 Million	118,578 Added 82.74%	261,890 $65.2 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $11.3 Million - $13.5 Million	52,266 Added 57.41%	143,312 $33 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $6.39 Million - $7.1 Million	27,213 Added 42.63%	91,046 $23.1 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $2.67 Million - $3.27 Million	13,491 Added 26.8%	63,833 $15.1 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $15.6 Million - $20.7 Million	-85,824 Reduced 63.03%	50,342 $10.2 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $23.2 Million - $29.9 Million	122,866 Added 923.8%	136,166 $32.8 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $45.7 Million - $54.8 Million	-262,603 Reduced 95.18%	13,300 $2.57 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $73.2 Million - $85.9 Million	-439,405 Reduced 61.43%	275,903 $50.8 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $129 Million - $145 Million	-712,563 Reduced 49.9%	715,308 $136 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $535,378 - $624,958	-3,001 Reduced 0.21%	1,427,871 $278 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $33.1 Million - $37.3 Million	178,595 Added 14.26%	1,430,872 $297 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $41.3 Million - $46.4 Million	248,884 Added 24.8%	1,252,277 $231 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $53.2 Million - $62.2 Million	-314,101 Reduced 23.84%	1,003,393 $171 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $702,166 - $784,534	-4,160 Reduced 0.31%	1,317,494 $229 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $221 Million - $252 Million	1,321,654	1,321,654 $246 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Amgen Inc Transaction History